3BYM: Proto-oncogene tyrosine-protein kinase LCK

X-ray co-crystal structure aminobenzimidazole triazine 1 bound to Lck. Determined by X-ray diffraction at 2.0 Å resolution. Released 16 Sept 2008.

Method
X-ray diffraction
Resolution
2.0 Å
Organism
Homo sapiens
Chains
1
Atoms
2,527
Mol. weight
32.22 kDa
Ligands
AM0
Released
16 Sept 2008

Explore 3BYM in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

3BYM contains 18 α-helices and 14 β-strands across 1 chain. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 18 helices, 14 β-strands

ElementResiduesLengthSheet
β-strand23911
α-helix242-2443
β-strand245-254101
β-strand257-26481
β-strand268-27581
α-helix2761
α-helix282-29413
β-strand30012
α-helix301-3022
β-strand303-30751
α-helix3121
β-strand313-31751
β-strand32312
α-helix324-3274
α-helix331-3344
α-helix338-35720
β-strand360-36123
α-helix367-3693
β-strand370-37232
β-strand378-38032
β-strand387-38823
β-strand394-39524
α-helix409-4146
β-strand416-41724
α-helix419-43416
α-helix438-4392
α-helix446-45510
α-helix459-4624
α-helix467-47610
α-helix481-4833
α-helix485-4862
α-helix487-50014

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Proto-oncogene tyrosine-protein kinase LCKAprotein272Homo sapiensP06239 (AlphaFold model)
Sequence of entity 1 (A), FASTA
>3BYM_1 Proto-oncogene tyrosine-protein kinase LCK (chains A)
QKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEA
NLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA
EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP
EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL
YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT

Ligands and cofactors

IDNameFormulaCopies
AM0N-phenyl-1-{4-[(3,4,5-trimethoxyphenyl)amino]-1,3,5-triazin-2-yl}-1H-benzimidaz…C25 H23 N7 O31

Water and common crystallization additives (SO4) are not listed.

Primary citation

Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. Martin, M.W., Newcomb, J., Nunes, J.J. et al. J Med Chem (2008) 51:1637-1648. DOI 10.1021/jm701095m · PubMed

Other PDB entries of the same protein (UniProt P06239 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 3BYM directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.